TY - JOUR
T1 - Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool
AU - Glöckner, Verena
AU - Dalhoff, Klaus
AU - Rohde, G.
AU - Rupp, Jan
AU - Witzenrath, M.
AU - Barten-Neiner, G.
AU - Kolditz, M.
AU - Dreher, M.
AU - Cornelissen, C.
AU - Knüppel, W.
AU - Stolz, D.
AU - Suttorp, N.
AU - Creutz, P.
AU - Witzenrath, M.
AU - Mikolajewska, A.
AU - le Claire, A.
AU - Benzke, M.
AU - Bauer, T.
AU - Krieger, D.
AU - Prediger, M.
AU - Schmager, S.
AU - Kolditz, M.
AU - Schulte-Hubbert, B.
AU - Langner, S.
AU - Rohde, G.
AU - Degen, O.
AU - Hüfner, A.
AU - Hoffmann, C.
AU - Welte, T.
AU - Freise, J.
AU - Barten-Neiner, G.
AU - Nawrocki, M.
AU - Fuge, I.
AU - Freise, J.
AU - Naim, J.
AU - Kröner, W.
AU - Illig, T.
AU - Klopp, N.
AU - Kroegel, C.
AU - Moeser, A.
AU - Pletz, M.
AU - Schleenvoigt, B.
AU - Bahrs, C.
AU - Drömann, D.
AU - Parschke, P.
AU - Franzen, K.
AU - Rupp, Jan
AU - Käding, N.
AU - Wouters, M.
AU - for the CAPNETZ study group
AU - Waldeck, F.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/4
Y1 - 2022/4
N2 - There are few data on mortality after discharge with community-acquired pneumonia (CAP). Therefore, we evaluated risk factors for 30-day post-discharge mortality after CAP. We included all patients of the prospective multi-national CAPNETZ study between 2002 and 2018 with (1) hospitalized CAP, (2) survival until discharge, and (3) complete follow-up data. The study endpoint was death within 30 days after discharge. We evaluated risk factors including demographics, comorbidities, admission CAP severity, and laboratory values and treatment-related factors in uni- and multivariable analyses. A total of 126 (1.6%) of 7882 included patients died until day 30 after discharge, corresponding to 26% of all 476 deaths. After multivariable analysis, we identified 10 independent risk factors: higher age, lower BMI, presence of diabetes mellitus, chronic renal or chronic neurological disease (other than cerebrovascular diseases), low body temperature or higher thrombocytes on admission, extended length of hospitalization, oxygen therapy during hospitalization, and post-obstructive pneumonia. By addition these factors, we calculated a risk score with an AUC of 0.831 (95%CI 0.822–0.839, p < 0.001) for prediction of post-discharge mortality. Early post-discharge deaths account for ¼ of all CAP-associated deaths and are associated with patient- and CAP-severity-related risk factors. Additional studies are necessary to replicate our findings in independent cohorts. Study registration: NCT 02139163.
AB - There are few data on mortality after discharge with community-acquired pneumonia (CAP). Therefore, we evaluated risk factors for 30-day post-discharge mortality after CAP. We included all patients of the prospective multi-national CAPNETZ study between 2002 and 2018 with (1) hospitalized CAP, (2) survival until discharge, and (3) complete follow-up data. The study endpoint was death within 30 days after discharge. We evaluated risk factors including demographics, comorbidities, admission CAP severity, and laboratory values and treatment-related factors in uni- and multivariable analyses. A total of 126 (1.6%) of 7882 included patients died until day 30 after discharge, corresponding to 26% of all 476 deaths. After multivariable analysis, we identified 10 independent risk factors: higher age, lower BMI, presence of diabetes mellitus, chronic renal or chronic neurological disease (other than cerebrovascular diseases), low body temperature or higher thrombocytes on admission, extended length of hospitalization, oxygen therapy during hospitalization, and post-obstructive pneumonia. By addition these factors, we calculated a risk score with an AUC of 0.831 (95%CI 0.822–0.839, p < 0.001) for prediction of post-discharge mortality. Early post-discharge deaths account for ¼ of all CAP-associated deaths and are associated with patient- and CAP-severity-related risk factors. Additional studies are necessary to replicate our findings in independent cohorts. Study registration: NCT 02139163.
UR - http://www.scopus.com/inward/record.url?scp=85124335733&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/ea3c0bbb-5c20-34f0-9899-3522af6b605a/
U2 - 10.1007/s10096-022-04416-5
DO - 10.1007/s10096-022-04416-5
M3 - Journal articles
C2 - 35137301
AN - SCOPUS:85124335733
SN - 0934-9723
VL - 41
SP - 621
EP - 630
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
IS - 4
ER -